Study confirms: ”Safe-Cut®” from SOMATEX^® considerably improves handling in bone marrow punctures and quality of the biopsy material obtained.

Teltow, May 26, 2005. Bone marrow punctures are indispensable for diagnosing numerous hematological and oncological diseases. Due to the patient’s enormous stress and the risk of infection it is very important that the first attempt of puncture already yields enough bone marrow material in sufficient quality.

According to a study carried out by ArtiMed Medical Consulting, there are clear advantages of new puncture systems compared to the standard puncture systems. Based on clinical routine studies, a total of 60 bone marrow punctures at the iliac crest were evaluated. In 31 cases the physicians used the Safe-Cut system from SOMATEX^® Medical Technologies and in 29 cases the TrapLok® system from InterV.

Both puncture systems led to a considerably reduced traumatization of the patients. The quantity of obtained biopsy material was considered as sufficient with both systems as well. With regard to the effort required to penetrate the bone crest, however, the study stated a “considerable advantage of the Safe-Cut system compared to the TrapLok system.”

The pathologists, too, achieved good results with both Safe-Cut and TrapLok. As to the quality of the biopsy material, the authors of the study come to the following conclusion: ”Summarizing we can say that both systems have advantages compared with standard puncture systems when looking at the biopsy material’s quality. These advantages are more obvious when using the Safe-Cut system since the pathologist's examinations have not been impaired in any case.”

Information about Safe-Cut
Safe-Cut is a new system allowing the puncture and aspiration of histological tissue from the iliac crest. The puncture system is characterized by its special LOCK-WIRE technology that ensures a 100% retention of the biopsy material in the canula and an optimal protection of the specimen and care of the patient.

Hematology - Oncology SAFE-CUT^® 

Information on SOMATEX^® 
The company SOMATEX^® Medical Technologies GmbH specializes in the development and manufacturing of disposable minimally invasive instruments in the areas of tumor ablation, vertebroplasty, biopsy and oncology.
In addition to the manufacturing of standard instruments for diagnostic and therapeutical procedures, SOMATEX^® develops innovative special products and new instruments based on what treating physicians precisely need. Since 1992, the company constantly develops new medical therapy concepts and realizes them in their products in close cooperation with physicians, hospitals and university clinics. Its focus is set on methods and instruments allowing minimally invasive operations using magnetic resonance imaging. In the past few years, the SOMATEX^® has also intensified its activities aiming at the development of new procedures and instruments used to treat painful vertebral compression fractures, for example caused by osteoporosis.

No fees to be paid for publication. Please send specimen copy to:

Press Contact
unlimited communications berlin
Mr. Torsten Krüger
Rosenthalerstr. 40/41
D-10178 Berlin
Tel. 030 / 280078-63
E-Mail: tkrueger@ucm.de

Contact SOMATEX
SOMATEX Medical Technologies GmbH
Ms. Anja Schlicht
Rheinstr. 7d
D-14513 Teltow
Tel +49 (0) 3328 / 30 76-12
E-Mail: a.schlicht@SOMATEX.com